Nvidia says generative AI will revolutionize health care. So did IBM, with Dr. Watson Casey Ross By Casey Ross March 25, 2024

https://www.statnews.com/2024/03/25/nvidia-generative-ai-hype-health-care-ibm-watson/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=299647194&_hsenc=p2ANqtz-_3Rsjd6scqBY64hVS_hSlmGXOVDIBY6iNSPQ8mtThDAKSxqPJmsWSqlCktD3MOKDQHs4psUORBGyeaovfFjaVA7vw8lg&utm_content=299647194&utm_source=hs_email Will generative AI actually revolutionize health care? Health systems, drugmakers, and insurers are racing to build artificial intelligence technology into their operations, aligning themselves with corporate giants such as Microsoft, Google, and Nvidia, whose executives speak about each incremental advancement of AI as an earth-shattering event. “The generative AI revolution is here,” Jensen Huang, 61, Nvidia’s leather-jacket-clad CEO, declared during the company’s GTC conference in San Jose, Calif., last week. Maybe. The technology is undeniably getting more powerful and more beneficial to businesses in health care and beyond. But many physicians, chemists, and computer scientists also fear that the overheated rhetoric — and the thinly veiled profit motives behind it — will inevitably result in yet another letdown. And health care should have already learned this lesson a decade ago, STAT’s Casey Ross writes. IBM overhyped its Watson supercomputer during the deep learning run-up as a cancer cure, only to have its health care business collapse under the weight of its own exaggerations. So is it worth holding our breath on generative AI? Read more to find out.